FDA Inspection 1235775 — Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
The FDA completed an inspection of Guangdong Blue Treasure Pharmaceuticals Co. Ltd. on Mar 15, 2024 in Qingyuan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 15, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qingyuan (China)